课题基金 / 基金详情

PHASE I/II MULTICENTER, OPEN LABEL STUDY OF THE EFFICACY OF PROLEASE HGH

PHASE I/II MULTICENTER, OPEN LABEL STUDY OF THE EFFICACY OF PROLEASE HGH
PROLEASE HGH 功效的 I/II 期多中心、开放标签研究
批准号：
6297771
负责人：
MITCHELL GEFFNER
金额：
$0.19万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6297771
关键词：
child (0-11) clinical research clinical trial phase I drug screening /evaluation endocrine disorder chemotherapy hormone therapy human subject human therapy evaluation longitudinal human study pediatric pharmacology pituitary dwarfism postnatal growth disorder somatotropin

项目摘要

项目成果

MITCHELL GEFFNER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The specific aim of this 6-month phase I/II study is to demonstrate the safety and efficacy of a new sustained-release formulation of hGH in the treatment of growth failure in children with GH deficiency. Efficacy will be assessed using 3 and 6 moth annualized growth rates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EVAL OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AND ADRENOMEDULLARY FUNCTION
STUDIES TO TREAT OR PREVENT PEDIATRIC TYPE 2 DIABETES (STOPP-T2D): TREATMENT
CLINICAL TRIAL: STUDIES TO TREAT OR PREVENT PEDIATRIC TYPE 2 DIABETES (STOPP-T2D
STUDIES TO TREAT OR PREVENT PEDIATRIC TYPE 2 DIABETES (STOPP-T2D): TREATMENT
海外基金